Pancreatic Cancer Research

ResearcherInstituto de Investigación Marqués de ValdecillaActive in the last 2 years

Eva Martínez de Castro

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-5772-0741; OpenAlex author ID A5002421509, A5109281822. Sources: ClinicalTrials.gov.

Their work

Papers
3
Trials
1 (principal investigator on 1)
Grants
0
Labs led
0
Collaborators
32
Papers, trials and grants by year

2020: 1 paper · 2021: none · 2022: none · 2023: 1 trial · 2024: none · 2025: 1 paper · 2026: 1 paper

Papers 3

  1. Intravenous hyaluronidase-expressing oncolytic adenovirus with chemotherapy in metastatic pancreatic cancer: a randomized phase 2b trial. Co-author DOI 10.1038/s41591-026-04705-y↗
  2. Real-world management and outcome of patients with pancreatic adenocarcinoma. Results of the Spanish RETUD gastrointestinal registry. Co-author DOI 10.1016/j.esmorw.2025.100116↗
  3. A comprehensive analysis of candidate genes in familial pancreatic cancer families reveals a high frequency of potentially pathogenic germline variants. Co-author DOI 10.1016/j.ebiom.2020.102675↗

Trials 1

  1. Study of Nab-Paclitaxel and Gemcitabine and Plus/Minus VCN-01 in Patients With Metastatic Pancreatic Cancer Principal investigator NCT05673811↗

Closest collaborators

The 25 strongest of 32 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Carmen Guillén‐Ponce · 1 shared paper, 1 shared trial, 2023–2026 · strength 0.43
  2. Roberto Pazo-Cid · 2 shared papers, 2025–2026 · strength 0.40
  3. Teresa Mercade Macarulla · 2 shared papers, 2025–2026 · strength 0.40
  4. Alfredo Carrato · 2 shared papers, 2020–2025 · strength 0.27
  5. Mireya Cazorla · 1 shared trial, 2023 · strength 0.22
  6. Andrés Muñoz · 1 shared trial, 2023 · strength 0.22
  7. Teresa Macarulla · 1 shared trial, 2023 · strength 0.22
  8. Roberto Pazo · 1 shared trial, 2023 · strength 0.22
  9. Rocío García · 1 shared trial, 2023 · strength 0.22
  10. Alana TH Nguyen · 1 shared trial, 2023 · strength 0.22
  11. Christopher Nevala-Plagemann · 1 shared trial, 2023 · strength 0.22
  12. Arjun Mittra · 1 shared trial, 2023 · strength 0.22
  13. Berta Laquente · 1 shared trial, 2023 · strength 0.22
  14. Miriam Lobo · 1 shared trial, 2023 · strength 0.22
  15. Inmaculada Gallego · 1 shared trial, 2023 · strength 0.22
  16. Edward Kim · 1 shared trial, 2023 · strength 0.22
  17. Alexander I. Spira · 1 shared trial, 2023 · strength 0.22
  18. Tara E Seery · 1 shared trial, 2023 · strength 0.22
  19. MD, FACP Vivek R Sharma · 1 shared trial, 2023 · strength 0.22
  20. Luis Alfonso Rojas · 1 shared paper, 2026 · strength 0.21
  21. Rocio García‐Carbonero · 1 shared paper, 2026 · strength 0.21
  22. Edward Jae-Hoon Kim · 1 shared paper, 2026 · strength 0.21
  23. Chris Nevala-Plagemann · 1 shared paper, 2026 · strength 0.21
  24. Manuel M. Hidalgo · 1 shared paper, 2026 · strength 0.21
  25. Andrés Jesús Muñoz Martín · 1 shared paper, 2025 · strength 0.18

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.